Results 221 to 230 of about 19,401 (288)

Progress and Challenges in Faba Bean Genetic Engineering

open access: yesLegume Science, Volume 8, Issue 2, June 2026.
ABSTRACT Legumes are essential for global food security, serving as a vital source of plant‐based protein and playing a significant role in sustainable agricultural practices. Among legumes, faba bean (Vicia faba L.) is noteworthy due to its high‐protein content, broad climate adaptation, and suitability for cultivation in temperate regions.
Simone A. Gierlich   +7 more
wiley   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 6, Page 1383-1398, June 2026.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan   +4 more
wiley   +1 more source

Diabetic Peripheral Neuropathy: Molecular Staging, Risk Factors, Therapeutics, and Emerging Trends

open access: yesMed Research, Volume 2, Issue 2, Page 309-342, June 2026.
The heterogeneous landscape of DPN can be unified through a tripartite pathogenic model encompassing progressive stages of metabolic dysregulation, chronic inflammation, and overt neuronal damage. Within this framework, six clinical subtypes were identified, namely, hyperglycemia‐driven, dyslipidemia‐driven, inflammation‐driven, dysvascularity‐driven ...
Xiaofeng Dai, Mingze Tang
wiley   +1 more source

Fermentation and Enzymatic Pre‐Treatments to Modulate Sensory Properties of Extruded Plant‐Based Meat Alternatives

open access: yesSustainable Food Proteins, Volume 4, Issue 2, June 2026.
Fermentation, enzymatic hydrolysis, and enzymatic crosslinking are emerging pre‐treatments to improve the sensory properties of extruded plant‐based meat alternatives. This review critically examines current literature to identify underlying mechanisms, benefits, and key research gaps associated with these pre‐treatments.
Ravinder Singh   +3 more
wiley   +1 more source

Managing micronutrients in metabolic and bariatric surgery: A mixed methods study of Australian dietitians' practice and perspectives

open access: yesNutrition &Dietetics, Volume 83, Issue 3, Page 312-325, June 2026.
Abstract Aims Dietitians play key roles in the care of patients undergoing metabolic and bariatric surgery, including micronutrient management. This study aimed to explore Australian dietitians' practices and perspectives on managing micronutrients in bariatric surgery.
Xueying Tang   +5 more
wiley   +1 more source

Limnofasciculus delicatus (Coleofasciculaceae, Coleofasciculales), a Novel Mat‐Forming Cyanobacterium From Shenandoah River, Virginia, USA

open access: yesEnvironmental Microbiology Reports, Volume 18, Issue 3, June 2026.
A novel mat‐forming benthic freshwater cyanobacterium, Limnofasciculus delicatus, is described based on morphological, phylogenetic and genomic evidence from the North and South Forks of the Shenandoah River. Although Limnofasciculus delicatus lacks biosynthetic gene clusters associated with the production of known cyanotoxins, it occurs in association
Rosalina Stancheva   +5 more
wiley   +1 more source

Metabolic Flux Analysis Reveals Entner–Doudoroff Pathway Dominance in Heterotrophic Deep‐Sea Bacterial Isolates

open access: yesEnvironmental Microbiology Reports, Volume 18, Issue 3, June 2026.
Four deep‐sea bacterial strains, isolated from sediments at the water depths of 1–10 km, exhibited diverse metabolic flux patterns in central carbon metabolism as well as differing antioxidative responses. ABSTRACT Deep‐sea microorganisms adapt to extreme conditions by diverse metabolic strategies, yet their intracellular carbon fluxes remain largely ...
Yuxue Yang   +7 more
wiley   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy